Health
OXGENE launches a scalable, plasmid-free manufacturing system for AAV – News-Medical.net
OXGENE™, a biotechnology company designing and developing scalable gene therapy technologies, has today announced the launch of its scalable, plasmid-free manufacturing system for AAV.
OXGENE™, a biotechnology company designing and developing scalable gene therapy technologies, has today announced the launch of its scalable, plasmid-free manufacturing system for AAV. OXGENE’s new TESSA™ technology addresses industry-wide challenges associated with robust and reproducible AAV manufacture at scale. These include high cost of goods, and low packaging efficiency. TESSA aims to deliver a paradigm shift in scalable AAV manufacture.
Adeno-associated virus, or AAV, is a popular choic…
-
Noosa News24 hours agoNRL announces preliminary finals dates, Melbourne Storm on Friday, Brisbane Broncos play Sunday
-
Noosa News23 hours agoMurdered woman accused of ‘cop shopping’ days before her horrific death, inquest hears
-
General20 hours agoTimor-Leste students protest government plan to buy new cars for parliamentarians
-
General23 hours agoLive updates: World Athletics Championships 2025 in Tokyo, Day 3, men’s pole vault